“…Recently, the seromucoid which has an electrophoretic mobility similar to that of alpha 1 and alpha 2 globulins has been found to include the specific binding ( 19,30). The total seromucoids are increased in human subject5 with neoplastic disease, trauma, inflammation, degenerative tissue changes, and in certain tumor bearing animals, (1, 8,22,31). However, the data in the present study do not disclose any relationship of vitamin B i g serum binding capacity to diseases other than most cases of chronic myelocytic leukemia, about half of the patients with polycythemia Vera, myeloid metaplasia with antecedent histories of polycythemia or chronic myelocytic leukemia, and some cases of acute myeloblastic and lymphoblastic leukemia.…”